Position Summary
- Sr. Scientist (In Vivo Pharmacology), Cell Therapy Thematic Research Center: Lead discovery and development of novel engineered immune effector cell therapeutics for cancer and other chronic diseases.
Position Responsibilities
- Lead functional workstreams on highly matrixed cell therapy projects from target concept to IND.
- Represent in vivo pharmacology on cross-functional teams; influence scientific decisions and provide clear recommendations.
- Independently design, execute, and interpret complex in vivo pharmacology studies; determine next steps based on results.
- Author scientific documents (presentations, study reports, protocols, publications); contribute to regulatory and IP filings.
- Present complex concepts to governance and departmental audiences.
- Integrate literature, emerging technologies, and immunotherapy modalities to improve study design.
- Supervise and mentor research colleagues; provide day-to-day technical support.
- Work effectively in a fast-paced environment; meet deadlines across multiple projects.
Basic Qualifications
- Bachelorโs degree with 7+ years academic/industry experience OR
- Masterโs degree with 5+ years academic/industry experience OR
- Ph.D. (or equivalent) in Life Sciences with 2+ years academic/industry experience.
Preferred Qualifications / Required Skills
- Ph.D. in Immunology, Cancer Biology, Virology, or related field; expertise in in vivo immuno-oncology models and immune effector cell biology.
- 4+ years post-degree industry experience in immune-based therapies/in vivo immunology/engineered cell therapies.
- Advanced murine tumor model development (syngeneic, xenograft, and/or T-cell driven); experience designing studies informing mechanistic understanding and therapeutic advancement.
- Familiarity with gene editing technologies and delivery (AAV, non-viral delivery, CRISPR).
- Proven scientific authorship (reports/publications) and contributions to patents/regulatory documentation.
Compensation (Seattle, WA)
- $136,030 - $164,841 (additional incentives may be available).